These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8791009)

  • 61. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Properties of chimeric secretin and VIP receptor proteins indicate the importance of the N-terminal domain for ligand discrimination.
    Vilardaga JP; De Neef P; Di Paolo E; Bollen A; Waelbroeck M; Robberecht P
    Biochem Biophys Res Commun; 1995 Jun; 211(3):885-91. PubMed ID: 7598719
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Role of second extracellular loop in the function of human vasoactive intestinal polypeptide/pituitary adenylate cyclase activating polypeptide receptor 1 (hVPAC1R).
    Knudsen SM; Tams JW; Fahrenkrug J
    J Mol Neurosci; 2000 Jun; 14(3):137-46. PubMed ID: 10984189
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Photoaffinity labeling demonstrates physical contact between vasoactive intestinal peptide and the N-terminal ectodomain of the human VPAC1 receptor.
    Tan YV; Couvineau A; Van Rampelbergh J; Laburthe M
    J Biol Chem; 2003 Sep; 278(38):36531-6. PubMed ID: 12807902
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immunohistochemical localization of the VIP1 receptor (VPAC1R) in rat cerebral blood vessels: relation to PACAP and VIP containing nerves.
    Fahrenkrug J; Hannibal J; Tams J; Georg B
    J Cereb Blood Flow Metab; 2000 Aug; 20(8):1205-14. PubMed ID: 10950381
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist.
    Waelbroeck M; Robberecht P; Coy DH; Camus JC; De Neef P; Christophe J
    Endocrinology; 1985 Jun; 116(6):2643-9. PubMed ID: 2859987
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
    J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Receptors for pituitary adenylate cyclase-activating peptide in human liver.
    Guijarro LG; Rodriguez-Henche N; García-López E; Noguerales F; Dapena MA; Juarranz MG; Prieto JC
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2451-7. PubMed ID: 7629241
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The somatostatin receptor is directly coupled to adenylate cyclase in GH4C1 pituitary cell membranes.
    Koch BD; Schonbrunn A
    Endocrinology; 1984 May; 114(5):1784-90. PubMed ID: 6143660
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Peptide specificity for stimulation of corticotropin secretion: activation of overlapping pathways by the vasoactive intestinal peptide family and corticotropin-releasing factor.
    Westendorf JM; Schonbrunn A
    Endocrinology; 1985 Jun; 116(6):2528-35. PubMed ID: 2859986
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Functional receptors for vasoactive intestinal peptide on human osteosarcoma cells.
    Hohmann EL; Tashjian AH
    Endocrinology; 1984 Apr; 114(4):1321-7. PubMed ID: 6323142
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cloning and expression of a complementary DNA encoding the bovine receptor for pituitary adenylate cyclase-activating polypeptide (PACAP).
    Miyamoto Y; Habata Y; Ohtaki T; Masuda Y; Ogi K; Onda H; Fujino M
    Biochim Biophys Acta; 1994 Aug; 1218(3):297-307. PubMed ID: 8049255
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tryptophan 67 in the human VPAC(1) receptor: crucial role for VIP binding.
    Nicole P; Maoret JJ; Couvineau A; Momany FA; Laburthe M
    Biochem Biophys Res Commun; 2000 Sep; 276(2):654-9. PubMed ID: 11027527
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Constitutive activation of the human vasoactive intestinal peptide 1 receptor, a member of the new class II family of G protein-coupled receptors.
    Gaudin P; Maoret JJ; Couvineau A; Rouyer-Fessard C; Laburthe M
    J Biol Chem; 1998 Feb; 273(9):4990-6. PubMed ID: 9478946
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Vasoactive intestinal peptide (VIP) stimulates [Ca2+]i and cyclic AMPin CHO cells expressing Galpha16.
    Langer I; Perret J; Vertongen P; Waelbroeck M; Robberecht P
    Cell Calcium; 2001 Oct; 30(4):229-34. PubMed ID: 11587546
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphoblastic membranes.
    Gourlet P; De Neef P; Woussen-Colle MC; Vandermeers A; Vandermeers-Piret MC; Robberecht P; Christophe J
    Biochim Biophys Acta; 1991 Jul; 1066(2):245-51. PubMed ID: 1649637
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 2. Effect of VIP on cAMP production and on cell-surface VIP-binding sites.
    Martin JM; Luis J; Marvaldi J; Pichon J; Pic P
    Eur J Biochem; 1989 Mar; 180(2):435-9. PubMed ID: 2538331
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Peptidergic activation of transcription and secretion in chromaffin cells. Cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP).
    Taupenot L; Mahata SK; Wu H; O'Connor DT
    J Clin Invest; 1998 Feb; 101(4):863-76. PubMed ID: 9466982
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A receptor for VIP-related peptides with an unusual selectivity profile on the melanoma cell line IGR37.
    Fabre C; Bellan C; Marvaldi J; Luis J
    Melanoma Res; 1994 Dec; 4(6):379-83. PubMed ID: 7703717
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characterization of a guanosine-nucleotide-binding-protein-coupled receptor for pituitary adenylate-cyclase-activating polypeptide on plasma membranes from rat brain.
    Schäfer H; Schwarzhoff R; Creutzfeldt W; Schmidt WE
    Eur J Biochem; 1991 Dec; 202(3):951-8. PubMed ID: 1662620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.